Bone Biologics (BBLG) Return on Invested Capital (2012 - 2022)

Bone Biologics (BBLG) has 10 years of Return on Invested Capital data on file, last reported at 0.01% in Q3 2022.

• Return on Invested Capital for Q3 2022 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was 0.01% (changed N/A YoY), and the FY2021 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital eased to 0.01% in Q3 2022 per BBLG's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q2 2018 and troughed at 0.01% in Q3 2022.
• A 4-year average of 0.0% and a median of 0.0% in 2020 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 3 bps in 2018 and fell as far as 1 bps in 2018.
• A 4-year view of Return on Invested Capital shows it stood at 0.0% in 2018, then slumped by 41 bps to 0.0% in 2019, then slumped by 71 bps to 0.0% in 2020, then sank by 1027 bps to 0.01% in 2022.
• Business Quant data shows BBLG's Return on Invested Capital at 0.01% in Q3 2022, 0.0% in Q2 2022, and 0.0% in Q1 2022.